Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Rybak

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Biochemistry|January 16, 1996
Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domainsD L Newton, Y Xue, K A Olson, et al.
Protein Engineering|April 1, 1997
Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapyD L Newton, Y Xue, L Boqué, et al.
Blood|January 12, 2001
Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphomaD L Newton, H J Hansen, S M Mikulski, et al.
Cell Biophysics|August 1, 1992
Rational immunotherapy with ribonuclease chimeras. An approach toward humanizing immunotoxinsS M Rybak, H R Hoogenboom, D L Newton, et al.
The Journal of Biological Chemistry|November 4, 1992
Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamilyS K Saxena, S M Rybak, R T Davey, et al.
The Journal of Biological Chemistry|September 25, 1992
Cytotoxic ribonuclease chimeras. Targeted tumoricidal activity in vitro and in vivoD L Newton, O Ilercil, D W Laske, et al.
Biochemical and Biophysical Research Communications|July 14, 1989
C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogeninS M Rybak, D S Auld, D K St Clair, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1992
Humanization of immunotoxinsS M Rybak, H R Hoogenboom, H M Meade, et al.
Immunotechnology : an International Journal of Immunological Engineering|June 1, 1997
Cloning and cytotoxicity of a human pancreatic RNase immunofusionM Zewe, S M Rybak, S Dübel, et al.
Biochemical and Biophysical Research Communications|October 14, 1994
Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonucleaseJ J Lin, D L Newton, S M Mikulski, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Biochemistry|January 16, 1996
Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domainsD L Newton, Y Xue, K A Olson, et al.
Protein Engineering|April 1, 1997
Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapyD L Newton, Y Xue, L Boqué, et al.
Blood|January 12, 2001
Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphomaD L Newton, H J Hansen, S M Mikulski, et al.
Cell Biophysics|August 1, 1992
Rational immunotherapy with ribonuclease chimeras. An approach toward humanizing immunotoxinsS M Rybak, H R Hoogenboom, D L Newton, et al.
The Journal of Biological Chemistry|November 4, 1992
Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamilyS K Saxena, S M Rybak, R T Davey, et al.
The Journal of Biological Chemistry|September 25, 1992
Cytotoxic ribonuclease chimeras. Targeted tumoricidal activity in vitro and in vivoD L Newton, O Ilercil, D W Laske, et al.
Biochemical and Biophysical Research Communications|July 14, 1989
C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogeninS M Rybak, D S Auld, D K St Clair, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1992
Humanization of immunotoxinsS M Rybak, H R Hoogenboom, H M Meade, et al.
Immunotechnology : an International Journal of Immunological Engineering|June 1, 1997
Cloning and cytotoxicity of a human pancreatic RNase immunofusionM Zewe, S M Rybak, S Dübel, et al.
Biochemical and Biophysical Research Communications|October 14, 1994
Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonucleaseJ J Lin, D L Newton, S M Mikulski, et al.
Pageof 6